Company Filing History:
Years Active: 2002-2015
Title: Tadeusz Kochel: Innovator in Medical Detection and Vaccine Development
Introduction
Tadeusz Kochel is a notable inventor based in Frederick, MD, who has made significant contributions to the fields of medical detection and vaccine development. With a total of three patents to his name, Kochel's work focuses on innovative methods for diagnosing diseases and preparing vaccines.
Latest Patents
Kochel's latest patents include groundbreaking inventions such as "Methods and biomarkers for the detection of dengue hemorrhagic fever." This invention provides methods for detecting, analyzing, and identifying biomolecules that help identify patients with dengue-like symptoms who are at risk of developing dengue hemorrhagic fever (DHF). The method involves detecting specific biomarkers in samples from dengue-infected patients, which are used in a predictive model to assess the risk of DHF. Another significant patent is the "Psoralen-inactivated viral vaccine and method of preparation." This patent outlines a method for preparing an inactivated viral vaccine by exposing the virus to a specific concentration of an inactivating psoralen and a preselected intensity of ultraviolet radiation, ensuring the virus becomes non-infectious while maintaining its antigenic characteristics.
Career Highlights
Throughout his career, Kochel has worked with esteemed organizations, including the United States Navy and the University of Texas System. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Kochel has collaborated with notable colleagues such as Kevin R. Porter and Kanakatte Raviprakash, further enhancing his research and development efforts in the medical field.
Conclusion
Tadeusz Kochel's contributions to medical detection and vaccine development highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to advancing medical science and addressing critical health challenges.